Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Editorials17 September 2002Specialist Evaluation in Chronic Kidney Disease: Too Little, Too LateNorman G. Levinsky, MDNorman G. Levinsky, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-6-200209170-00016 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Maintenance of patients with end-stage renal disease (ESRD) on long-term dialysis is a triumph of modern medicine. In the United States alone, more than 250 000 persons with ESRD, who otherwise would have died, enjoy life—usually of good quality—because of the availability of hemodialysis and peritoneal dialysis. Yet this triumph has a tragic flaw: The lifespan of dialysis patients remains abnormally short. Only about one third survive 5 years. Even patients who start dialysis in their 40s have no more than a 50% chance to live 5 more years (1).Nephrologists caring for patients receiving long-term dialysis have studied and ...References1. United States Renal Data System. 2001 Annual Data Report. Bethesda: National Institute of Diabetes and Digestive and Kidney Diseases; 2001:498. Google Scholar2. Obrador GT, Pereira BJ. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kid Dis. 1998;31:398-417. [PMID: 9506677] CrossrefMedlineGoogle Scholar3. Ismail N, Neyra R,…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The nonsteroidal mineralocorticoid antagonist finerenone is also recommended for kidney and heart protection in T2D with eGFR >25 mL/min/1.73 m2, normal serum potassium concentration, and albuminuria (UACR ≥ 30 mg/g) despite a maximally tolerated dose of a renin-angiotensin system inhibitor, because it reduced risks of substantial GFR decline, kidney failure, HF and ASCVD events, and related death”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [482]
In the citing paper
“Consultation with a nephrologist when stage 4 CKD develops has been found to reduce cost, improve quality of care, and keep people off dialysis longer (253,254).”
From Standards of Medical Care in Diabetes—2009 (2009) · cites this paper as [253]
Citations
Cites
Jafar, T. H., Schmid, C. H., Landa, M., Giatras, I., Toto, R., Remuzzi, G., Maschio, G., Brenner, B. M., Kamper, A., Zucchelli, P., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-2-200107170-00007 · Cited by 1,092
The Timing of Specialist Evaluation in Chronic Kidney Disease and Mortality
Kinchen, K. S., Sadler, J., Fink, N., Brookmeyer, R., Klag, M. J., Levey, A. S., & Powe, N. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00007 · Cited by 458
Chronic Renal Diseases: Renoprotective Benefits of Renin–Angiotensin System Inhibition
Remuzzi, G., Ruggenenti, P., & Perico, N. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00010 · Cited by 272
Obrador, G., & Pereira, B. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9506677 · Cited by 232
Morbidity and Mortality of Renal Dialysis: An NIH Consensus Conference Statement
Panel., C. D. C. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-1-199407010-00013 · Cited by 222
Ismail, N., Neyra, R., & Hakim, R. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.2.246 · Cited by 78
How can we improve prognosis in diabetic patients with end-stage renal disease?
Ritz, E., Koch, M., Fliser, D., & Schwenger, V. (1999) · PubMed · Cited by 24
Research works printed but not linked: 1
- Ritz E, 1999, Diabetes Care, 22, B80
Cited by
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“Consultation with a nephrologist when stage 4 CKD develops has been found to reduce cost, improve quality of care, and keep people off dialysis longer (438).”
BackgroundStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“Consultation with a nephrologist when stage 4CKDdevelops has been found to reduce cost, improve quality of care, and keep people off dialysis longer (364).”
BackgroundStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Metadata
- Authors
- Levinsky, N. G.
- Corresponding author
- Levinsky, Norman G.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2002-09-17
- Volume
- 137
- Issue
- 6
- Pages
- 542-543
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2038312077
- Cited by
- 53
- References
- 7
- Citations by year
- 2022: 2 · 2020: 1 · 2017: 2 · 2015: 2 · 2014: 5 · 2013: 5 · 2012: 3
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Technology
- Keywords
- chronic kidney disease, end-stage renal disease, dialysis, nephrology referral, early referral, mortality, quality of life, renal replacement therapy, dialysis complications, nephrologist role, dialysis adequacy
- MeSH terms
- Humans, Kidney Failure, Chronic, Nephrology, Referral and Consultation, Time Factors, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late. https://app.cochat.ai/papers/10.7326/0003-4819-137-6-200209170-00016
- The paper
- Levinsky, N. G. (2002). Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-137-6-200209170-00016
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.